z-logo
open-access-imgOpen Access
Dolutegravir Use at Conception — Additional Surveillance Data from Botswana
Author(s) -
Mmakgomo Mimi Raesima,
Chibuike M Ogbuabo,
Vasavi Thomas,
Sara E. Forhan,
Gadzikanani Gokatweng,
Eldah Dintwa,
Chipo Petlo,
Catherine Motswere-Chirwa,
Elizabeth M. Rabold,
Sarah C. Tinker,
Shifawu Odunsi,
Sifelani Malima,
Omphemetse Mmunyane,
Thusoetsile Modise,
Kelame Kefitlhile,
Kunle Dare,
Mpho Letebele,
Michelle E. Roland,
Cynthia A. Moore,
Surbhi Modi,
Dhelia Williamson
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmc1908155
Subject(s) - dolutegravir , medicine , medline , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , political science , law
Dolutegravir Use and Birth Defects in Botswana Identifying birth defects associated with medication use is complex, given the infrequency of events. In this study conducted in Botswana, a slightly ...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom